A double blind trial of PF-08634404 + Chemo vs. Bevacizumab + Chemo in untreated colon cancer

An Interventional, Phase 3, Double-blind, Randomized Study To Evaluate The Efficacy And Safety Of Pf-08634404 In Combination With Chemotherapy Versus Bevacizumab In Combination With Chemotherapy In Treatment-naïve Participants With Metastatic Colorectal Cancer

Disease Types: Colon

Available at: Alleghany, Blacksburg, Roanoke, Salem, Wytheville

An Interventional, Phase 3, Double-blind, Randomized Study To Evaluate The Efficacy And Safety Of Pf-08634404 In Combination With Chemotherapy Versus Bevacizumab In Combination With Chemotherapy In Treatment-naïve Participants With Metastatic Colorectal Cancer

For Additional Information:

https://clinicaltrials.gov/study/NCT07222800?term=Pf-08634404&rank=4